Radiosynthesis and biodistribution of a histamine H3 receptor antagonist 4-[3-(4-piperidin-1-yl-but-1-ynyl)-[11C]benzyl]-morpholine: evaluation of a potential PET ligand
- 31 August 2006
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 33 (6) , 801-810
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- H3 Autoreceptors Modulate Histamine Synthesis through Calcium/Calmodulin- and cAMP-Dependent Protein Kinase PathwaysMolecular Pharmacology, 2005
- Histamine H3-Receptor-Induced Attenuation of Norepinephrine Exocytosis: A Decreased Protein Kinase A Activity Mediates a Reduction in Intracellular CalciumThe Journal of Pharmacology and Experimental Therapeutics, 2005
- The physiology of brain histamineProgress in Neurobiology, 2001
- Histamine H3 receptor activation selectively inhibits dopamine D1 receptor-dependent [3H]GABA release from depolarization-stimulated slices of rat substantia nigra pars reticulataNeuroscience, 1997
- Histamine H3 receptor‐mediated depression of synaptic transmission in the dentate gyrus of the rat in vitro.The Journal of Physiology, 1996
- Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptorsJournal of Neural Transmission, 1993
- Inhibition of noradrenaline release in the rat brain cortex via presynaptic H3 receptorsNaunyn-Schmiedeberg's Archives of Pharmacology, 1989
- Histamine H3 receptor-mediated inhibition of serotonin release in the rat brain cortexNaunyn-Schmiedeberg's Archives of Pharmacology, 1988
- Highly potent and selective ligands for histamine H3-receptorsNature, 1987
- Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptorNature, 1983